Trimetazidine therapy in Hypertrophic Cardiomyopathy
A Phase 2b randomised, double blind, placebo-controlled trial of trimetazidine therapy in patients with non-obstructive hypertrophic cardiomyopathy. - Trimetazidine therapy in hypertrophic cardiomyopathy A Phase 2b randomised, double blind, placebo-controlled trial of trimetazidine therapy in patients w ...